ADAMTS5
ADAMTS5[edit | edit source]
ADAMTS5 (A Disintegrin and Metalloproteinase with Thrombospondin Motifs 5) is an enzyme that belongs to the ADAMTS family of proteins. These proteins are characterized by their ability to cleave various substrates, including components of the extracellular matrix. ADAMTS5 is particularly known for its role in the degradation of aggrecan, a major component of cartilage.
Structure[edit | edit source]
ADAMTS5 is a zinc-dependent metalloproteinase. It contains several distinct domains, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, a thrombospondin type 1 motif, and a spacer domain. The structure of ADAMTS5 allows it to interact with and cleave specific substrates in the extracellular matrix.
Function[edit | edit source]
The primary function of ADAMTS5 is the cleavage of aggrecan, a proteoglycan found in cartilage. This activity is crucial in the process of cartilage remodeling and degradation. ADAMTS5 is involved in normal physiological processes such as embryonic development and tissue repair, but it is also implicated in pathological conditions like osteoarthritis, where excessive aggrecan degradation leads to cartilage breakdown.
Clinical Significance[edit | edit source]
ADAMTS5 has been identified as a key enzyme in the pathogenesis of osteoarthritis. Inhibiting ADAMTS5 activity is a potential therapeutic strategy for preventing cartilage degradation in osteoarthritis. Research is ongoing to develop specific inhibitors that can target ADAMTS5 without affecting other metalloproteinases.
Regulation[edit | edit source]
The activity of ADAMTS5 is regulated at multiple levels, including gene expression, post-translational modifications, and interaction with tissue inhibitors of metalloproteinases (TIMPs). Understanding these regulatory mechanisms is important for developing targeted therapies.
Research[edit | edit source]
Current research on ADAMTS5 focuses on understanding its precise role in cartilage biology and its potential as a therapeutic target. Studies are also exploring the development of small molecule inhibitors and monoclonal antibodies that can specifically inhibit ADAMTS5 activity.
Also see[edit | edit source]
ADAMTS5 | |
---|---|
Identifiers | |
Symbol | ? |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD